Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FKBC0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,579
Award facts
- Contract value 100% obligated
- $1,579.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $1,579.22 delivery order to DMS Pharmaceutical Group Inc. on June 1, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for Xolair 150 mg/ml syringes.
DMS Pharmaceutical Group Inc. is a woman-owned small business serving as the sole regional prime vendor under PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract with a $499.999 billion ceiling running through December 31, 2036. Place of performance is Park Ridge, Illinois. The order matures on June 23, 2026.
Quick answers
Who was awarded contract SPE2DR26FKBC0?
SPE2DR26FKBC0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 1, 2026.
How much is contract SPE2DR26FKBC0 worth?
The government has obligated $1,579 on SPE2DR26FKBC0.
Is contract SPE2DR26FKBC0 an order under another contract?
Yes. SPE2DR26FKBC0 is a delivery order under SPE2DR25D9365, an indefinite delivery contract.
Was contract SPE2DR26FKBC0 competed?
The extent of competition for SPE2DR26FKBC0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award